In sharp contrast with these findings, physiological NO levels produced by the MDSCs of cancer patients or endogenously by CD4+ T cells expressing iNOS can induce and stabilize the Th17 phenotype (Obermajer et al., 2013). The gene discussed is NOS2; the disease is cancer.